Podcasts about lvad

Diagnosed with end-stage heart failure, Sofia walks us through the mysterious early symptoms, her emergency hospitalization, and the rapid decision to receive an LVAD that now keeps her alive. You can follow Sofia on TikTok here.

With Justyna Sokolska, Institute of Heart Diseases, Wroclaw Medical University, Wroclaw - Poland, and Maja Cikes, University of Zagreb School of Medicine, Head at the Unit for Heart Failure and Mechanical Circulatory Support, Department of Cardiovascular Diseases, University Hospital Center, Zagreb - Croatia. In this episode of HFA CardioTalk, Justyna Sokolska interviews Maja Cikes on the challenges in management of long-term left ventricular assist device in patients with advanced heart failure. The discussion emphasizes the importance of selecting appropriate patients at the optimal time, examines the adverse events and highlights major ongoing clinical trials.  Recommended readings:  Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial, Mehra MR, et al. JAMA. 2023 Dec 12;330(22):2171-81  Trends and Outcomes of Left Ventricular Assist Device Therapy: JACC Focus Seminar, Varshney AS, et al. J Am Coll Cardiol 2022 Mar 22;79(11):1092-1107 Cardiac implantable electronic devices with a defibrillator component and all-cause mortality in left ventricular assist device carriers: results from the PCHF-VAD registry, Cikes M, et al. Eur J Heart Fail 2019 Sep;21(9):1129-41 A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report, Mehra MR, et al. N Engl J Med 2019 Apr 25;380(17):1618-27 This 2025 HFA Cardio Talk podcast series is supported by Bayer AG in the form of an unrestricted financial support. The discussion has not been influenced in any way by its sponsor.

In this episode of Nurse Converse, Shenell Thompkins is joined by Tiffany Cannon, who shares her powerful story of living with a Left Ventricular Assist Device (LVAD). At just 28, Tiffany experienced heart failure during pregnancy, leading to an emergency C-section and the life-changing decision to receive an LVAD. She opens up about the emotional toll, her return to nursing, and how her dual perspective as both a patient and nurse fuels her passion for advocacy, empathy, and patient empowerment. Tiffany's journey is one of resilience and hope, proving that heart disease is not the end—but a new beginning. >>One Nurse's Journey with LVAD (Left Ventricular Assistive Device)Jump Ahead to Listen: [02:17] Tiffany's journey to heart failure.[05:53] Heart failure diagnosis after childbirth.[09:23] Divine intervention in medical decisions.[13:25] Gratitude through life changes.[21:00] Bridging patient-nurse connection.[22:49] Advocacy and patient awareness.[26:18] Heart disease is not a death sentence.[29:09] Supporting nurses in their careers.Connect with Shenell on social media:Instagram: allonenurse_shenell  TikTok: all_one_nurseFor more information, full transcript and videos visit Nurse.org/podcastJoin our newsletter at nurse.org/joinInstagram: @nurse_orgTikTok: @nurse.orgFacebook: @nurse.orgYouTube: Nurse.org

Returning for a second study this month, the JHLT Digital Media Editors invite first author Charlotte Van Edom to discuss the paper, “Apixaban plasma levels in patients with HeartMate 3 support.” As a cardiologist in training and a PhD candidate at the University Hospitals Leuven in Belgium, Van Edom's work focuses on hemocompatibility and mechanical circulatory support, covering both short-term and long-term support. The episode explores: The evolution of the use and understanding of direct oral anticoagulants (DOACs) during LVAD support, including the increased focus on Factor Xa inhibitors Encouraging findings from the study and what clinical practices might need to change if introducing apixaban Additional studies exploring DOACs in LVAD patients For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. Treat or research pulmonary vascular diseases? Check out the first April episode for a study on sotatercept in PAH patients. Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

Wie verändert ein Kunstherz, genauer ein linksventrikuläres Herzunterstützungssystem (LVAD) das Leben? Was geht im Alltag noch, was nicht mehr? Bernhard Wendel hat vor einem Jahr ein solches LVAD implantiert bekommen. Seine Lebensfreude und die Lust am Theater hat der Regisseur des Exiltheaters nicht verloren. Doch manche Improvisation ist nötig, wie er im diesem zweiten Teil des Gesprächs erzählt. Hören Sie rein!

Können Sie sich vorstellen, jeden Tag ein kleines lebensrettendes Gerät mit sich führen zu müssen? Nein, kein Handy – sondern ein Herzunterstützungs-System, auch einfach Kunstherz genannt. Bernhard Wendel, Regisseur des Exiltheaters Bruchsal, trägt seit einem Jahr ein solches System in und mit sich. Denn das Batteriesystem muss immer in einer Tasche mit dabei sein - Tag und Nacht. Im ersten Gesprächsteil erzählt er, mit einem Augenzwinkern, wie dieses besondere “Drama” seinen Lauf nahm.

Imagine working as a nurse, but you must stay attached to battery packs to stay alive. That's the reality for Tiffany Davis Cannon, RN—full-time nurse, mother, and LVAD patient. After being diagnosed with peripartum cardiomyopathy, she had to adapt to life with an LVAD—but it's been anything but easy.In this episode, Tiffany candidly shares the emotional and physical challenges of living with an LVAD, how her experience changed her approach to nursing, and what she wants other nurses to know about caring for LVAD patients. Tune in to hear how she's embraced her new normal and turned her experience into an opportunity to advocate for patients!Topics discussed in this episode:Early signs of peripartum cardiomyopathyTiffany's birth story and descent into heart failureMaking the decision to get an LVADHow the LVAD works and the implantation processThe reality of living life with an LVADChallenges of working as a nurse with an LVADHow her experience changed her approach to patient careCommon LVAD emergenciesTips for treating LVAD patientsHear more from Tiffany:FB: https://www.facebook.com/tiffany.cannon.397/IG: https://www.instagram.com/tiffany_cannon90/Email: Tiffany.cannonjourney@gmail.comPurchase her book, A Journey Through Supernatural Healing!https://a.co/d/av53sriMentioned in this episode:CONNECT

SHOW NOTES 2:25 – heart transplant at age 29, no previous cardiac issues3:00 – post-partum cardiomyopathy3:30 – placed on a Life Vest and a low ejection fraction4:30 – a 49-day stay in the hospital5:15 – the fear of leaving one's children behind, without a mom6:15 – emergency room, to a two-week stay, to “we've done all we can for you”7:00 – options and prognosis regarding Cassidy's heart8:30 – praying and deciding to move forward with a heart transplant9:45 – ECMO10:15 – shifting one's perspective during and after a heart transplant11:00 – Cassidy's mom, cardiomyopathy, and her heart transplant months after Cassidy's12:00 – the wait for a heart, and testing for the best match, for improved outcomes13:00 – antibodies after pregnancy can affect transplant success14:20 – a ten-hour surgery14:50 – the new heart needs to wake up16:00 – the importance of family and a support system17:30 –Dr. Allene Magill, an influential leader in education, and in Cassidy's life19:00 – Cassidy's decision to change her career path change21:00 – Shifting plans to find the “sweet spot” for one's work22:30 – teaching and learning, equal importance23:00 – organ donors changes lives and save lives25:00 – donor family and recipient interaction25:30 – a donor's organ can be classified as high-risk26:00 – How does life change when you have someone else's heart replace your own?27:15 – Piedmont Cartersville, Piedmont Atlanta, Samsky Heart Failure Clinic28:00 – great teachers…29:15 – Matt Fox, Becky Reynolds30:00 – Cassidy's closing comments LINKSCardiomyopathyECMOEjection FractionLifeVestTM - Cleveland Clinic pageLifeVestTM - Zoll pageLVADOrgan Donation - American Society of TransplantationOrgan Donation - Donate LifeOrgan Donation - UNOSPiedmont CartersvillePiedmont AtlantaSamsky Heart Failure CenterFairmount Elementary SchoolRed Bud Middle SchoolSonoraville High School   Music for Lead. Learn. Change. is Sweet Adrenaline by Delicate BeatsPodcast cover art is a view from Brunnkogel (mountaintop) over the mountains of the Salzkammergut in Austria, courtesy of photographer Simon Berger, published on www.unsplash.com.Professional Association of Georgia EducatorsDavid's LinkedIn pageLead. Learn. Change. the book

In this episode of the Better Edge podcast, Anjan Tibrewala, MD, discusses his paper published in Circulation: Heart Failure, “Impact of Heart Transplant Allocation Change on Waitlist Mortality and Posttransplant Mortality in Patients With Left Ventricular Assist Devices.”The study's results found that despite the 2018 heart transplant allocation change deprioritizing patients with LVADs, patients with LVADs are living longer on the heart transplant waitlist. Interestingly, the study also demonstrated that patients with LVADs have slightly higher mortality after heart transplant following the allocation change. Dr. Tibrewala discusses recent advances in LVAD technology and what's next in advanced heart failure care.

In this episode of AbbottTalks, Kartik Sundareswaran, PhD, divisional VP, global clinical and regulatory affairs, Abbott Heart Failure, discusses Abbott's pioneering work in heart failure care, focusing on technologies that improve outcomes and empower earlier interventions. Sundareswaran's path to MedTech began with a shift from computer engineering to biomedical research, where his early work studying blood flow patterns in children with congenital heart disease sparked a passion for solving cardiovascular challenges. This passion led him to roles at Thoratec, St. Jude Medical, and ultimately Abbott, where he has spent years advancing heart failure care. The conversation highlights Abbott's CardioMEMS™ Heart Failure System, a device enabling remote pulmonary artery pressure monitoring to reduce hospitalizations, and the HeartMate 3 LVAD, which provides life-extending support for patients with advanced heart failure. Sundareswaran also discusses the new TEAM-HF clinical trial, which combines CardioMEMS and HeartMate 3 to identify patients earlier and deliver timely, effective interventions. This conversation comes to you courtesy of our episode sponsor, Tecan Group Ltd. To learn more about how Tecan works with medical device companies, visit: https://partnering.tecan.com/ Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.

Quentin R. Youmans, MD, MSc, and Alyssa M. Vela, PhD, discuss a recent paper they co-authored that explores the importance of addressing the unique psychosocial and emotional challenges faced by patients with advanced heart failure.

On the second November episode of JHLT: The Podcast, the Digital Media Editors continue MCS-month with a paper from the November issue of JHLT, entitled “Aortic insufficiency in the patient on contemporary durable left ventricular assist device support: A state-of-the-art review on perioperative and postoperative assessment and management.”  First author Diyar Saeed, MD, PhD, of the Heart Center Niderrhein, and senior author Jennifer Cowger, MD, MS, of Henry Ford Hospitals both join the podcast. You'll hear about: Why LVAD patients develop new and progressive aortic regurgitation—and how contemporary devices may differ Associated hemodynamic events Intraoperative surgical techniques Slowing the progression of the condition and monitoring it post-op Early interventions For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. If you haven't yet tuned in for the first November episode of the podcast, MCS enthusiasts will be happy to know the paper discusses temporary MCS devices in acute RV failure. Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.  

0:00- Intro               0:30- Andrew's story               15:00- LVAD               19:00- Heart transplant               52:00- Andrew's training               57:00- Movie talk 

On this episode of JHLT: The Podcast, the Digital Media Editors discuss a new guidelines document from the ISHLT entitled “The 2024 ISHLT Guidelines for the Evaluation and Care of Cardiac Transplant Candidates.” The lead co-authors of the document—Yael Peled, MD, and Anique Ducharme, MD, MSc—are on the podcast to discuss the document. You'll hear about: Challenges in drafting such an overarching document Highlights for clinicians Major changes in the document since the last version How changes in durable and temporary MCS affect use of the document For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. Join us again later this month for a study on age matching in lung transplantation. Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

with DNV host Simile Miller and Renee Cecil, and Houston Methodist Hospital guests, -Laurie Loza, MBA, BSN, NE-BC, CCTC ,Director Thoracic Transplant & LVAD, Methodist Transplant Center -Neal Waxali, Mech Circulatory Support Specialist -Clement Tabermejo, MBA, RN, CCTC, Clinical Operations Manager Heart/VAD & MCS

Hey heart buddies, this episode is truly extraordinary. Try to imagine plugging your heart in at night to keep it beating. Yeah, I can't imagine it either. I say this often when I have the honor of interviewing heart transplant recipients and this time is no different. Allow me to introduce you to Christian Jousset. Christian, after facing a daunting heart failure diagnosis in 2015, navigated a world of medical treatments, surgical procedures, and life-saving devices (say hello to the heartmate 3/LVAD that kept Christian alive!). He is now thriving post heart transplant!!! Christian's story is a testament to unwavering resilience and personal growth. Christian candidly discusses his mindset shift, the importance of support groups, and his exciting new goals, including writing a book and coaching others. This episode guarantees to captivate your senses and provide valuable lessons in overcoming adversity. Christian highlights the profound strength and boundless potential within us all. Thank you, Christian, for your willingness to share your story with the world. ***Support the show!*** Your financial support means so much to me and fellow heart patients. Thank you for considering donating today.The following gene likely contributed to Christian's need for a new heart: TTN titin [Homo sapiens (human)] - Gene - NCBI (nih.gov)About Christian Jousset: An effective bilingual communicator, I take pleasure in seeing everyone succeed. I strongly believe in everyone's potential and strive to help them discover their strengths and abilities. I have over 30 years of international experience with an organic approach and connection to my diverse participants or clients. I have held various positions in continuing education in higher education, in management in the catering industry, as well as in HR and customer services in the medical and sports industries, focusing on group management and consulting for the realization of international projects. What I observed and retained was the potential of the people I met, as well as the need for constant motivation and positive, constructive leadership.Professional experience: Nike (European headquarters Netherlands), Angiodynamics (New York and European headquarters Amsterdam), Concentrix (Customer Service Amsterdam), Rouen Business School (NEOMA), CESI/EXIA (Rouen region), Taste Catering New York, Potel et Chabot Catering New York, Peet's Coffee and Tea (San Francisco), the French American International School (San Francisco)**I am not a doctor and this is not medical advice. Be sure to check in with your care team about all the next right steps for you and your heart.**How to connect with BootsEmail: Boots@theheartchamberpodcast.comInstagram: @openheartsurgerywithboots or @boots.knightonLinkedIn: linkedin.com/in/boots-knightonBoots KnightonIf you enjoyed this episode, take a minute and share it with someone you know who will find value in it as well. You can share directly from this platform or send them to:Open Heart Surgery with Boots

In this episode recorded at the Emerald Coast Conference, we interview Dr. Jaron Raper about two of his topics that both involve the chest, a pulmonary embolism update and the managing LVAD issues in the community ED.

UH MedAir's Kyle Schnarrs, Flight Nurse and Nathan Brazytis, Flight Paramedic continue to talk about the airmedical transport system.  First, they address the medical brief that can be helpfu to the communications specialists and the flight crew, distinctions between VFR flying and IFR flying for the crew, patients needing LVAD transportation as well as the most recent billing rules.  What is practical?

John Daniel has led a remarkable and inspiring life, marked by challenges that he's met with grit and resilience.  John's alcoholic father struggled to find work but his loving mom made sure her nine children always had the support they needed.  John emerged from his childhood to become a successful banking executive with a successful marriage and thriving children.  But following his own diagnosis of a serious heart ailment, his wife developed cancer and passed away.  A few short years later, John faced a major heart procedure and ultimately, a full transplant.  With the support of his second wife, Leslie, John persevered, got back on his feet, and resumed his career.  Now retired from banking, John and Leslie have co-founded Bluff City Pickleball, a community center in their hometown of Memphis, Tennessee designed to bring people together from all walks of life and economic backgrounds.      Chapters: 02:09 Childhood Challenges and Resilience John describes his challenging childhood in a working-class neighborhood with nine siblings and a father battling alcoholism and says these early experiences shaped his grit and resilience, setting the foundation for his future successes.  06:52 “Advantages of Disadvantages” Explore the concept of finding advantages in disadvantages as discussed by John Daniel and Malcolm Gladwell. Understand how facing challenges and adversity can lead to personal growth and strength, as highlighted in John's own experiences.  13:40 Personal Loss and Resilience John describes his personal journey of love, loss, and resilience, from his marriage to his wife's battle with cancer and eventual passing.   16:00 Health Challenges and Heart Transplant Discussion of John's health challenges, including his heart ailment and the eventual need for a heart transplant.   23:35 Transplant Procedure and Recovery John describes his journey through the heart transplant procedure and the challenging recovery process.   26:37 Recovery from LVAD Surgery John discusses the challenging recovery process after his LVAD surgery, including infections, transfusions, and the support he received from his wife during a low point.  29:26 Setting Goals for Recovery John shares how setting a vision of returning to work and accomplishing a 50-mile bike ride post-transplant helped him stay motivated and focused during his recovery.  34:31 Founding Bluff City Pickleball John shares the inspiration behind starting Bluff City Pickleball, a community center aimed at fostering social connections and physical activity, emphasizing inclusivity and social impact.  42:15 Ancestral Minds Book John discusses his upcoming book ‘Ancestral Minds,' focusing on human nature and evolutionary psychology, offering insights for effective leadership based on understanding innate behaviors.  49:44 Words of Encouragement John offers words of encouragement for those facing tough times, emphasizing the importance of surrounding oneself with supportive and optimistic individuals to maintain hope and resilience. 

On this episode of JHLT: The Podcast, the JHLT Digital Media Editors explore two studies from the June issue of The Journal of Heart and Lung Transplantation. Digital Media Editor Van-Khue Ton, MD, a transplant cardiologist from Massachusetts General Hospital, hosts this episode.   First, Dr. Ton and Digital Media Editor Marty Tam, MD, interview their first guests, first author Matthew Carey, MD, MBA, and senior author Justin Fried, MD, both of the Columbia University Irving Medical Center in New York City, on their study “Aortic Root Thrombosis in patients with HeartMate 3 left ventricular assist device support.”   This retrospective study of all patients receiving a HeartMate 3 LVAD at a single center between November 2014 and August 2020. The study evaluated findings related to patients with aortic root thrombosis, classified as having at least 1 echocardiogram or contrast-enhanced CT scan with thrombus. In the population of 197 patients, 19 had aortic root thrombus, which was ultimately associated with an increased risk of developing significant aortic regurgitation during the study period.   Drs. Carey and Fried discuss whether aortic valve opening is associated with increased risk of aortic root thrombus, how to balance the bleeding-thrombosis scale in patients, and how the study fits in the context of prior generations of LVAD.   Next, Dr. Ton joins and Digital Media Editor Erika Lease, MD, FCCP, to interview, Jacqueline DesJardin, MD, a Fellow in the department of medicine at the University of California San Francisco. Dr. DesJardin is first author on the study “Investigating the “sex paradox” in pulmonary arterial hypertension: Results from the Pulmonary Hypertension Association Registry (PHAR).”   PHAR is a multicenter US-based registry of patients with PAH, and this study analyzed 1,891 patients from the registry, 1,425 (75%) of whom were female. At baseline, compared to men, women had worse functional status and worse hemodynamics. Women were more likely to be on triple therapy or parenteral prostacyclin therapies at baseline. Interestingly, women had better survival than men, even after adjusting for numerous variables.   In the discussion, Dr. DesJardin explains what collider stratification bias is, and how it may illuminate the complex epidemiological system that creates this disparity. She shares the three potential causal models posed in the study, and considers how the study might be followed up.   Follow along at www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.   Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.    

On this episode of JHLT: The Podcast, the JHLT Digital Media Editors explore two studies from the April issue of The Journal of Heart and Lung Transplantation. Digital Media Editor Erika Lease, MD, a transplant pulmonologist at the University of Washington in Seattle, hosts this episode.   First, Dr. Lease and Digital Media Editor Van-Khue Ton, MD interview their first guests, Paul J. Scheel III, MD and Steven Hsu, MD, both of Johns Hopkins University. Dr. Scheel was first author and Dr. Hsu was senior author on the study “Occult right ventricular dysfunction and right ventricular-vascular uncoupling in left ventricular assist device recipients.” The main finding of the study is that LVAD recipients have depressed intrinsic RV contractility and reduced RV compensation.   Drs. Scheel and Hsu give an overview of RV pressure-volume loops and their measurements, and discuss the impact of LVAD on intrinsic RV contractility, contractile reserve, and vascular coupling. If you want to know how these findings are important to clinical care, you'll need to listen to the episode!   Next, Dr. Lease and Digital Media Editor David Schibilsky, MD, interview their next guest, Joshua Diamond, MD, of the University of Pennsylvania. Dr. Diamond was first author on the study “Development and validation of primary graft dysfunction predictive algorithm for lung transplant candidates.” The authors of the study set out to develop a clinically useful and generalizable PGD prediction model to aid in clinical decision making.   Dr. Diamond discusses the factors they considered in building the model, the model's strengths over other approaches, and its limitations. Tune in to learn more!   Follow along at www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.   Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.    

In today's episode, I am joined by Rhys Thomas, a former International Rugby Player, Inspirational Speaker, Mental Health Ambassador, Mentor, and Charity Co-Founder. He details his extraordinary life journey, sharing the profound lessons he has learned from facing adversity and rebuilding his life after a life-altering event.Rhys takes us back to the early 2000s, where he had a thriving international sports career as a capped Welsh rugby player. His sporting career was on an upward trajectory until he suffered a massive heart attack during training. This event marked the beginning of a transformative journey that would redefine his identity.The heart attack left Rhys with irreparable damage, leading to retirement from professional sport, and  to the installation of an LVAD pump—a mechanical heart. Struggling with his new reality, Rhys turned to destructive behaviours, including heavy drinking. His mental health rapidly deteriorated as he grappled with the loss of identity that came with the end of his athletic career.Rhys discusses his experiences in rehab as a turning point in his life. The non-judgmental space provided an opportunity for self-realisation, allowing him to cope with accumulated shame, guilt, and sadness. In this safe environment, Rhys learned the power of vulnerability, gaining clarity, reconnecting with his values, and ultimately finding peace within himself.With a newfound sense of authenticity and purpose, Rhys details his post-rehab journey. He shares how he translated his adverse experiences into lessons and developmental opportunities.

with guest host Jamie Jeffcoat and special guests Dr. Kathryn O'Keefe and Pam Smith from Tri- Health Bethesda North

In this episode of CTSNet's flagship podcast, editor in chief Joel Dunning runs through the latest, most popular content on ctsnet.org—the largest online community of CT surgeons and source of CT surgery information—and breaking cardiothoracic surgery news and research from around the world. Joel discusses the long-term risk of stroke after TAVR, invasive hemodynamic assessments in LVAD patients, and the implications of the 2022 congenital heart surgery practice survey. He also talks about a video demonstrating tips, tricks, and pitfalls for cardiopulmonary bypass, another installment of the TAVR redo surgery series, and a segmentectomy video. The next episode of The Beat will broadcast live from the STS annual meeting on Sunday, January 27th at 6:00 pm CST. Tune in! JANS Items Mentioned Long-Term Risk of Stroke After Transcatheter Aortic Valve Replacement: Insights from the SwissTAVI Registry  Value of Invasive Hemodynamic Assessments in Patients Supported by Continuous-Flow Left Ventricular Assist Devices  Workforce and Training Implications of the 2022 Congenital Heart Surgery Practice Survey  CTSNet Content Mentioned Tips, Tricks, and Pitfalls for Cardiopulmonary Bypass Mastering Redo Surgery after TAVR: TAVR Removal, Surgical AVR, and Ascending Aortic Replacement  Right VATS S7 and S8 Segmentectomy  Other Items Mentioned CTSNet Events Calendar The Beat LIVE! Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

Dr. Jordan Singer rejoins the team to talk about CPR and ROSC care. In the pre-recorded parts we talked about refractory VF, subglottic airways vs. endotracheal intubation,  being near a tertiary center vs. being in a rural setting, LVAD, pacemakers, traumas, and Lucas devices. New for this year we will be streaming from various EMS agencies under UH medical control and at a new later time. Thanks to Avon Fire Department for being the first to host the podcast.

Which of the following precautions is MOST appropriate to implement during physical therapy interventions with a patient with an implanted left ventricular assist device? Free NPTE Premium Course in Chicago, Feb 29-Mar 1 (Free housing and meals)   Find it all out in the podcast!  Be prepared for the NPTE so that you can pass with flying colors! Check out www.ptfinalexam.com/podcast for more information and to stay up-to-date with our latest courses and projects.

It's ROSC rapid fire question time with Dr. Singer.. LVAD, pacemakers, traumas and Lucas devices.  This part moves quickly!

CardioNerds (Dr. Josh Saef and Dr. Sumeet Vaikunth) join Dr. Sheng Fu, Dr. Payton Kendsersky, and Dr. Aniqa Shahrier from the Medical University of South Carolina for some off-shore fishing. They discuss the following featuring a patient with D-TGA and Eisenmenger's syndrome treated with a Heartmate 3. Expert commentary was provided by Dr. Brian Houston. The episode audio was edited by student Dr. Adriana Mares. A 39-year-old woman with a history of D-transposition of the great arteries (D-TGA) with prior atrial switch repair (Mustard) was admitted from the clinic with cardiogenic shock. She underwent right heart catheterization which demonstrated elevated biventricular filling pressures and low cardiac index. An intra-aortic balloon pump was placed, and the patient was evaluated for advanced therapies. A liver biopsy showed grade 3 fibrosis, which, in combination with her shock state, made her a high-risk candidate for isolated heart or combined heart-liver transplantation. After a multi-disciplinary discussion, the patient underwent a Heartmate III left ventricular assist device (LVAD) implant in her systemic right ventricle. Although she did well post-operatively, she was admitted after a month with recurrent cardiogenic shock, with imaging showing her inflow cannula had become perpendicular to the septum.  The patient and family eventually decided to pursue comfort measures, and the patient passed. US Cardiology Review is now the official journal of CardioNerds! Submit your manuscript here. CardioNerds Case Reports PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Case Media - D-TGA and Eisenmenger's syndrome treated with a Heartmate 3 Pearls - D-TGA and Eisenmenger's syndrome treated with a Heartmate 3 Early diagnosis of cyanotic congenital heart disease is paramount for treatment and prevention of future complications. Adult congenital heart disease requires a multi-disciplinary team for management in consultation with an adult congenital cardiology specialist. Eisenmenger syndrome is related to multiple systemic complications and has a high rate of mortality. Advancement in PAH medical management can offer noninvasive treatment options for some patients. Transthoracic echocardiography is the cornerstone for diagnosis. Other modalities (e.g. cardiac CT, cardiac MRI, invasive catheterization) can aid in diagnosis and management. Pearls - D-TGA and Eisenmenger's syndrome treated with a Heartmate 3 While advances in pediatric surgery have allowed many patients born with congenital heart disease to survive into adulthood, adult congenital heart disease (ACHD) patients are complex and prone to numerous adverse sequalae including arrhythmias, heart failure, valvular disease, and non-cardiac organ dysfunction. Heart failure can be a challenging presentation in ACHD patients due to a longstanding history of clinical compensation. Their unique and complex anatomy, as well as highly variable clinical presentation, present unique challenges when it comes to advanced heart failure options such as durable left ventricular assist devices (LVAD) or transplantation. While durable LVAD implantation is possible in patients with systemic right ventricles, anatomic compatibility is paramount and poses ongoing challenges in their management. Goals of care discussions should be had early, as options for treatment may be limited. Show Notes - D-TGA and Eisenmenger's syndrome treated with a Heartmate 3 What are some common sequelae in ACHD patients? ACHD patients are a heterogeneous population, but atrial tachycardias are extremely frequent in this patient population, often due to re-entrant pathways around surgical suture lines. These can often be treated with radiofrequency ablation while paying clos...

The following question refers to Section 8.5 of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. The question is asked by Western Michigan University medical student & CardioNerds Intern Shivani Reddy, answered first by University of Southern California cardiology fellow and CardioNerds FIT Trialist Dr. Michael Francke, and then by expert faculty Dr. Shashank Sinha. Dr. Sinha is an Assistant Professor of Medical Education at the University of Virginia School of Medicine and an advanced heart failure, MCS, and transplant cardiologist at Inova Fairfax Medical Campus. He currently serves as both the Director of the Cardiac Intensive Care Unit and Cardiovascular Critical Care Research Program at Inova Fairfax. He is also a Steering Committee member for the multicenter Cardiogenic Shock Working Group and Critical Care Cardiology Trials Network and an Associate Editor for the Journal of Cardiac Failure, the official Journal of the Heart Failure Society of America. The Decipher the Guidelines: 2022 AHA / ACC / HFSA Guideline for The Management of Heart Failure series was developed by the CardioNerds and created in collaboration with the American Heart Association and the Heart Failure Society of America. It was created by 30 trainees spanning college through advanced fellowship under the leadership of CardioNerds Cofounders Dr. Amit Goyal and Dr. Dan Ambinder, with mentorship from Dr. Anu Lala, Dr. Robert Mentz, and Dr. Nancy Sweitzer. We thank Dr. Judy Bezanson and Dr. Elliott Antman for tremendous guidance. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. Question #30 Ms. V. Tea is a 55-year-old woman with a history of cardiac sarcoidosis, heart failure with mildly reduced ejection fraction (HFmrEF – EF 40%), and ventricular tachycardia with CRT-D who presents with recurrent VT. She has undergone several attempts at catheter ablation of VT in the past and previously had been trialed on amiodarone which was discontinued due to hepatotoxicity. She now continues to have episodic VT requiring anti-tachycardia pacing and ICD shocks despite medical therapy with mexiletine, metoprolol, and sotalol. Her most recent PET scan showed no active areas of inflammation. Currently, her vital signs are stable, and labs are unremarkable. What is the best next step for this patient? A Evaluation for heart transplant B Evaluation for LVAD C Dobutamine D Prednisone E None of the above Answer #30 Explanation The correct answer is A – evaluation for heart transplant. For selected patients with advanced heart failure despite GDMT, cardiac transplantation is indicated to improve survival and quality of life (Class 1, LOE C-LD). Heart transplantation, in this context, provides intermediate economic value. Clinical indicators include refractory or recurrent ventricular arrhythmias with frequent ICD shocks. Patient selection for heart transplant includes assessment of comorbidities, goals of care, and various other factors. The United Network of Organ Sharing Heart Transplant Allocation Policy was revised in 2018 with a 6-tiered system to better prioritize unstable patients and minimize waitlist mortality. VT puts the patient as a Status 2 on the transplant list. There was a contemporary analysis of patients with end-stage cardiomyopathy due to cardiac sarcoidosis, published in Journal of Cardiac Failure, in 2018 that demonstrated similar 1-year and 5-year survival after heart transplant between patients with and without cardiac sarcoidosis. Choice B (evaluation for LVAD) is incorrect. While bridge to transplant with LVAD is definitely a potential next step in patients with cardiac sarcoidosis, it is not recommended in patients presenting primarily with refractory ventricular arrhythmias due to granuloma-induced scarring. In this situation, patients benefit from direct heart transplant rather than bridge to transplant LVAD approa...

Welcome to Protecting Your Nest with Dr. Tony Hampton. Dr. Funmmy Awoyomi is a PGY3 Internal Medicine Resident at Newark Beth Israel Medical Center in New Jersey specializing in the field of integrative medicine. Her work involves metabolic support for heart failure, LVAD, ECMO, heart transplant, lung transplant, wound care, and bariatric surgery. She is interested in metabolic strategies for restoring health and reversing obesity, metabolic mapping, chronic disease management, and pathways toward eliminating food deserts and health disparities. In this discussion, Drs. Tony and Funmmy talk about: (02:56) Favorite travel destinations (04:38) Gastronomy (06:16) LVAD and ECMO (09:17) The Metabolic Health education landscape (12:47) How Dr. Funmmy discovered the keto diet and became interested in metabolic health (17:01) Nigerian culture, food, and beauty standards (20:58) Things that Dr. Funmmy wishes she could see changed with regard to her patients and her practice (23:47) The growing appreciation for and acceptance of the keto diet among doctors (27:14) Intermittent fasting (30:10) Grains and enriched foods (33:16) Sleep hygiene (38:53) Dealing with stress (43:18) Health equity and inclusion (48:15) Spreading the metabolic health message Thank you for listening to Protecting Your Nest. For additional resources and information, please see the links below.   Links:   Dr. Funmmy Awoyomi: Instagram Podcast (That Metabolic Guy)   Dr. Tony Hampton: Linktree Instagram Account LinkedIn Account Ritmos Negros Podcast Q Med Symposium for Metabolic Health Lectures How Waking Up Every Day at 4:30 Can Change Your Life

In this episode from MEMA23 in Michigan, we chat with Dr. Matthew Kennedy about the evaluation and management of the most common LVAD presentations. It way be rare for most emergency departments, but it's important to know what to do when they show up.

Jodie Hall's story emphasizes the importance of putting oneself first and seeking support when facing health challenges. Her experience with congestive heart failure at a young age sheds light on the significance of early diagnosis and proper medical care.At 19, Jodie discovered that she had congestive heart failure. Despite this diagnosis, she continued with her daily life, not fully understanding the seriousness of her condition. It wasn't until she was in her thirties that she noticed the symptoms and sought medical attention. This delay in recognizing the severity of her condition highlights the importance of early diagnosis and regular check-ups.Jodie's journey also emphasizes the significance of seeking support from loved ones and medical professionals. When she was initially diagnosed, she faced the challenge of not being able to see her newborn son due to hospital regulations. However, her mother provided significant support during this time, ensuring that her son knew her identity and maintained a connection despite the physical separationThroughout her journey, Jodie emphasizes the importance of putting oneself first and taking care of one's own well-being. She recognizes the significance of rest, stress management, and proper nutrition in managing her condition. By prioritizing her health and needs, she is better equipped to care for others and face the challenges that come her way.In conclusion, Jodie Hall's experience with congestive heart failure at a young age highlights the importance of early diagnosis and proper medical support. Her journey showcases the resilience and determination of individuals facing health challenges. It serves as a reminder that it is possible to overcome adversity and live a fulfilling life with adequate support and mindset. By putting oneself first and seeking help from loved ones and medical professionals, individuals can navigate the challenges of a health diagnosis and find strength in their journey toward recovery..

Commentary by Dr. Valentin Fuster

Jenn speaks to Rhys Thomas founder of Rhys Thomas and Co-Founder of Tidy Butt. Rhys is a former Wales pro rugby player turned inspirational speaker and mentor who works on athlete transition, mental health & wellbeing, addiction & recovery, changing perspective and finding purpose! Rhys shares with us his amazing recovering journey from becoming disabled at 29 and how he navigated these physical and emotional challenges, how he overcame this dark period in his life and is now a helping others who face similar challenges in the work he does today. (Recorded on April 20, 2023)About Rhys:Rhys Thomas was a professional Welsh rugby player until his career was cut short by a life changing injury at the age of 29. After suffering a heart attack and undergoing a quadruple bypass and multiple operations, Rhys eventually was fitted with a pump that currently helps run his heart (LVAD). From losing his career, identity, relationships, not dealing with his emotions and feelings which led him to alcoholism and many dark places, Rhys went into rehab and sought support in which he has since sobered up and turned his life around sharing his story, breaking stigmas, supporting and mentoring others to maximize their own potential. Today he works with athletes and professionals to work on topics such as addition, athlete transition, confidence building and a healthy routine with complete anonymity and total confidentiality as well as co-founding a mental health charity Tidy Butt. Tidy Butt engages with schools, business and local authorities to try and make positive lasting changes in our community.Episode Resources: Website  IG  Tidy Butt  Linkedin  Email  The Power of Now  7 Habits of Highly Effective People  The Body Keeps the Score

Heart failure impacts more than 8 million people in the United States today, but with the right treatments, the course of the disease can be corrected. Dr. Nir Uriel is determined to do just that. He's spent his career pushing forward advancements to better diagnose and treat advanced heart failure patients. These advancements include a new, magnetic levitated pump that can improve the outcomes of patients denied transplantation due to their age or severity of disease, as well as breakthrough testing that analyzes cell-free DNA to detect transplant rejection, changing the course of immunosuppressive therapy. Dr. Uriel is also pioneering the use of technology to remotely monitor heart failure patients, and diagnose heart failure before symptoms even occur. In this episode, Dr. Uriel details his multifaceted methods to treating heart failure, the value of a team approach, and the importance of empathetic, patient-centered care.

His traditional Bosnian upbringing showed Armin Muzafirović the importance of hard work, determination, and having an unrelenting drive. These qualities would prepare Armin for the future fight of his life.At just sixteen-years old, Armin was diagnosed with a failing heart that would ultimately require constant medical attention. At only seventeen, Armin would have a pacemaker implanted into his chest. Just two years later, Armin had yet another surgery to receive an internal defibrillator, also known as an implantable cardioverter defibrillator (ICD). Additionally, he had a right ventricular assist device (RVAD) and a left ventricular assist device (LVAD) installed. These devices pump blood from one's right and left ventricle, respectively, into one's pulmonary artery and to the lungs.All of the aforementioned steps were crucial in keeping Armin alive while his heart continued to deteriorate. With an ejection fraction of only fifteen percent, and forty pounds of gained fluid around his heart, Armin was ultimately admitted to the hospital with a nonfunctional heart. He drifted in and out of consciousness over and over again. Hear as we speak on the long and tenuous months that followed his admission to the hospital. Then, experience his elation upon finally receiving the call he'd been waiting for. Some kind, dearly departed soul had chosen to give Armin his heart.Having received the ultimate gift of life, Armin now advocates and raises awareness regarding organ donation in every way imaginable, including the Iowa Donor Network. Armin co-founded and served as President of the Student Organ Donation Advocates Chapter (SODA) at the University of Northern Iowa, the very first SODA Chapter in the state of Iowa.Having since graduated from UNI, where he majored in biology and minored in chemistry, Armin plans to attend medical school with aspirations of becoming a surgeon.

Commentary by Dr. Valentin Fuster

The special challenge patient at times can be difficult for the EMS provider. In this episode we discuss some of the more frequent special challenge patients, including the obese patient, LVAD patient, and MR patient. Learn techniques to help in the care of these patients as well as a deep dive into how the LVAD device works. Hear from Mike (NY AEMT-P, CIC), Phil (NY AEMT-P), & Butch (NY AEMT-P).Join our Discord Community: https://discord.gg/8v4smgMEKeGet CE credit here: https://medicmaterialscmeacademy.thinkific.com/BECOME A VIP PROVIDER by joining our PATREON PAGE & receive instant access to our THIRD Monthly Podcast episode! Sign Up HERE: http://patreon.com/medicmaterials Buy us a Cup Of Coffee to help support the show: https://www.buymeacoffee.com/medicmaterials Podcast Links: LISTEN on your FAVORITE platform, just choose your LINK...https://linktr.ee/MedicMaterialsPodcast Do you have a great call you want us to review on a future episode? Email it to us: info.medicmaterials@gmail.com Grab some SWAG: https://bit.ly/3AtWg2TSend the show an email: info.medicmaterials@gmail.com Visit our Website: https://www.MedicMaterials.com/ See ALL our Links on our LINKTREE: https://linktr.ee/MedicMaterials Want your own custom wooden American Flag? Contact US Military Veteran Jared for more information. Instagram @Ledslinger85 DISCLAIMER: This audio is for Demonstration purposes only. The information provided in this audio is no replacement for proper EMT/Paramedic training, education, and or practice. The skills, techniques, ideas, and theories offered in this audio represent the individual participants featured in this audio and are not intended to showcase the only method of performing these skills. Please continue to consult with your local EMS system, Agency Standard Operating Procedures/Medical Director, Your Local and State Protocols, and your EMS educator for clarification and further proper EMT/Paramedic training.Intro Music: http://bit.ly/3wIaSbAOutro Music: https://rb.gy/tais0a Rig Check Music: http://bit.ly/3jlEVTrMicrophone Used: Rode Podmic Software Used In Production: Canva, Vegas 20, Rodecaster Pro

The partnership between Nuwellis and DaVita to launch an ultrafiltration therapy pilot program is an exciting development in the field of renal care. The agreement enables Nuwellis — formerly CHF Solutions — to pilot its Aquadex ultrafiltration therapy within selected U.S. markets. Fast Five hosts Sean Whooley and Danielle Kirsh discuss the partnership in detail and what executives say about it. CorWave's successful fundraising of $64 million is a significant milestone for the company as it prepares to manufacture its left ventricular assist device (LVAD). LVADs play a critical role in supporting patients with advanced heart failure, and CorWave's technology has the potential to improve patient outcomes and enhance their quality of life. Learn more about the company's technology and other developments in today's episode. Avanos Medical's decision to acquire Diros Technology is a strategic move demonstrating the company's commitment to expanding its portfolio and addressing unmet needs in the medical device market. Diros Technology makes radiofrequency products that are used to treat chronic pain conditions. Whooley explains how the acquisition will support Avanos' offerings and when the transaction will be completed. The FDA approval of Surmodics' SurVeil drug-coated balloon highlights the continued advancements in interventional cardiology and the increasing availability of innovative treatment options for patients with peripheral arterial disease (PAD). Hear how the technology stacks up against other devices in the market and how the company overcame being "unapprovable" earlier this year. BD's decision to sell its surgical instrumentation assets to Steris for $540 million marks a strategic move to streamline its portfolio and focus on core areas of expertise. This transaction enables BD to allocate resources more effectively and invest in research and development efforts that align with its long-term growth strategy. Whooley and Kirsh explain how BD will expand and how the acquisition will affect Steris' bottom line. Check out the show notes and links to the stories we discussed today at MassDevice.com/podcast.

If you love your job, you won't work a day in your life. We've all heard that quote before, but sometimes work is work and your co-workers and your supervisor make (or break) the environment. Tina describes what she desired in a leader and how she worked hard to embody that for her team. 18 years later, it is safe to say Tina loves her job.In this episode, Dr. Burriesci chats with Dr. Fields, the physical therapy supervisor and residency director of the University of Michigan Health. They burrow in deep on leadership ideals and what that looks like on the “Cards” team. They discuss how Tina has helped foster great culture in the PT department and across the hospital system. She describes acknowledging the “small things,” while also always having her therapist's back and empowering the strengths and knowledge of her staff. The goal is to provide great care and make an impact on patients' lives, while also being safe in a very medically complex environment. The only way to do that is by practicing at the top of your license. She states, “You can be the Ferarri or you can be the Pinto….”They dance through ideals, discuss specifics on competencies, spend time discussing the complexities of specific patient populations and they round out the episode by talking about what the University of Michigan's Cardiovascular and Pulmonary residency program looks like, including application timing, salary, and the opportunities available in the residency.In This Episode:How to foster a great culture in a physical therapy departmentIdeals of leadershipThe importance of practicing at the top of your licenseThe extensive nature of competencies in a complex hospital environmentImportant considerations for your LVAD (left ventricular assist device) patientThe discontinuation of the Syncardia Total Artificial HeartUniversity of Michigan's Cardiovascular and Pulmonary Residency programEnjoyed this episode? Find Rachele at:Podcast: Talking All Things CardiopulmIG: @all_things_cardiopulm
Website: www.allthingscardiopulm.com  

Episode 137: Heart Transplant and LVADFuture Doctor My explains two treatments for advanced heart failure, heart transplant and Left Ventricle Assist Device (LAVD). Dr. Arreaza adds historical information about the first artificial heart implant and the first LAVD.  Written by My Chau Nguyen, MSIV, American University of the Caribbean School of Medicine. Comments by Hector Arreaza, MD.  You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Introduction: Advanced heart failure is a major concern in the United States. Heart failure has a high 1-year mortality average of 33%. Although medical therapies have improved survival rates, some patients with progressive and advanced heart failure may still require heart transplantation or mechanical support such as left ventricular assist devices (LVADs) to prolong survival and improve quality of life.It is estimated that 23 million people in the world have heart failure, and many of them are in end-stage heart failure. When it comes to treating severe heart failure, there are two main options: heart transplantation and left ventricular assist devices (LVADs). Heart transplant: The operation to perform a heart transplant typically lasts between five to six hours but may take longer in patients who have undergone previous open-heart surgery or have an LVAD in place. However, because donors' hearts are a scarce resource, not all patients are eligible for transplantation. The following are absolute indications for referral for Heart Transplant listing:Cardiogenic shock requiring continuous intravenous inotropic therapy (i.e., dobutamine, milrinone, etc.) or circulatory support with intra-aortic balloon pump counterpulsation devices or left ventricular assist device (LVAD) to maintain adequate organ perfusion.Peak oxygen consumption VO2 (VO2max) less than 10 mL/kg per minute.New York Heart Association NYHA class III or IV despite maximized medical and resynchronization therapy.Recurrent life-threatening arrhythmias unresponsive to medical therapy such as an implantable cardiac defibrillator, medical therapy, or catheter ablation.End-stage congenital heart failure with no evidence of pulmonary hypertension.Refractory severe angina without potential medical or surgical therapeutic options.Selected patients with restrictive and hypertrophic cardiomyopathies.My experience with a heart transplant: I consider myself extremely fortunate for witnessing the whole complex procedure involved in lung and heart transplantation at Jackson Memorial Hospital in Miami, FL. It was an incredible experience to join the transplant team in retrieving a donor organ. Timing plays a critical role in heart transplants. When a suitable donor becomes available, every second counts. We must quickly arrange transport and secure an operating room. It is essential that the distance between the donor and the hospital is within our designated region. For example, we are in Region 5, including Arizona, California, Nevada, New Mexico, and Utah. Once everything is in order, we divide into two teams. One team sets off to retrieve the donor while the other prepares the patient in the operating room. It is a race against time, as hearts and lungs must be transplanted within approximately four hours of removal from the donor. It was remarkable to see how everything was so precisely scheduled, from the arrival and departure of the teams to the transplantation of the organs. It is an inspiring experience to witness these life-saving procedures in action.History of the artificial heart.Arreaza: It is great to hear about your experience, but we know that not everyone can have a heart transplant. So, let us talk about other options. For example, an artificial heart. I lived in Utah for several years and I heard something about the first artificial heart being implanted there, so here is the information. William DeVries was the surgeon who led the implantation of the first artificial heart, the Jarvik-7, at the University of Utah on December 1, 1982. The patient was a retired dentist, Barney Bailey Clark, who survived 112 days connected to the device. Today, the modern version of the Jarvik-7 is known as the SynCardia temporary Total Artificial Heart. It has been implanted in more than 1,350 people as a bridge to transplantation.Left Ventricular Assist Device (LVAD):In recent years, LVADs have become increasingly popular as a viable alternative to transplantation, as they have demonstrated improved durability by using wear-free components, greatly improving mortality rates in heart failure patients. Arreaza: The first left ventricular assist device (LVAD) system was created by Domingo Liotta at Baylor College of Medicine in Houston, Texas, in 1962. It is basically a pump that is used for patients who are on end-stage heart failure. The LVAD is surgically implanted, it is a battery-operated pump that helps the left ventricle pump blood to the rest of the body. LVADs can be used as a temporary treatment while patients are waiting for a transplant. It is called a “bridge-to-transplant therapy”. In some cases, an LVAD may restore a failing heart and eliminate the need for a transplant. An LAVD may also be used as a “destination therapy” in patients who are not candidates for heart transplants. LVAD can prolong and improve patients' quality of life.My: The purpose of an LVAD is to support patients with heart failure by increasing perfusion and reducing filling pressures in the heart. It is important to note, however, that LVADs only partially assist the pumping action of the diseased ventricle and cannot fully replace the function of the heart. Therefore, the decision to have an LVAD or heart transplant must be taken after careful discussion between the patient and the cardiologist to determine which option is best to reach the patient's goals of care.Example of an LVAD:Recently, The Berlin Heart Ventricular Assist Device (VAD) has been a game-changer in saving children with severe heart conditions. As you may guess from the name, it is developed in Germany. It is recently approved by US FDA in 2011. This type of LVAD has been used in approximately 1,000 children worldwide, including 12 cases in the United States. The Berlin Heart is a simple air-driven pump that takes over the work of one or both sides of a child's own heart. It pumps blood around the body to keep the brain and other organs healthy, allowing the child to grow and get stronger. The use of this device is required until the child is transplanted, or for a small number of children until their own heart recovers. I once again had the privilege of witnessing the procedure performed by one of the inventors, my preceptor, Dr. Loebe in the NICU at Jackson Memorial Hospital.Conclusion: Now we conclude episode number 137, “Heart Transplant and LVAD.” My explained two options for the treatment of advanced heart failure: Heart transplant and Left Ventricular Assist Device, or LVAD. She shared her recent experience in her surgery rotation at Jackson Memorial Hospital. Dr. Arreaza added the history of the first artificial heart implanted in Utah and the first LAVD. We hope you enjoyed it.This week we thank Hector Arreaza, and future doctor My Chau Nguyen. Audio editing by Adrianne Silva.Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________Sources:Theochari CA, Michalopoulos G, Oikonomou EK, Giannopoulos S, Doulamis IP, Villela MA, Kokkinidis DG. Heart transplantation versus left ventricular assist devices as destination therapy or bridge to transplantation for 1-year mortality: a systematic review and meta-analysis. Ann Cardiothorac Surg. 2018 Jan;7(1):3-11. doi: 10.21037/acs.2017.09.18. PMID: 29492379; PMCID: PMC5827119. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827119/.Alraies MC, Eckman P. Adult heart transplant: indications and outcomes. J Thorac Dis. 2014 Aug;6(8):1120-8. doi: 10.3978/j.issn.2072-1439.2014.06.44. PMID: 25132979; PMCID: PMC4133547. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133547/.Birks, E. J., & Mancini, D. (2022, November 9). Treatment of advanced heart failure with a durable mechanical circulatory support device. UpToDate. Retrieved April 21, 2023. https://www.uptodate.com/contents/treatment-of-advanced-heart-failure-with-a-durable-mechanical-circulatory-support-device.Drews T, Loebe M, Hennig E, Kaufmann F, Müller J, Hetzer R. The ‘Berlin Heart' assist device. Perfusion. 2000;15(4):387-396. doi:10.1177/026765910001500417.Middleton, J. (2021, August 26). What is the time frame for transplanting organs? Donor Alliance. Retrieved April 21, 2023, from https://www.donoralliance.org/newsroom/donation-essentials/what-is-the-time-frame-for-transplanting-organs/.The Bridge to Transplant Team, The Child and Family Information Group. (2017, July). Berlin Heart Mechanical Heart Assist. NHS choices. Retrieved April 21, 2023, from https://www.gosh.nhs.uk/conditions-and-treatments/procedures-and-treatments/berlin-heart-mechanical-heart-assist/.Royalty-free music used for this episode: "Tempting Tango." Downloaded on October 13, 2022, from https://www.videvo.net/

Dr. Fab Sagebin was born in the south of Brazil and grew up in Utah. He studied biology and chemistry at UVU before attending NYU School of Medicine. He trained in cardiothoracic surgery at the University of Rochester with an emphasis in advanced heart failure and mechanical heart technology. In 2019, he was recruited to Southern California where he started Orange County's first mechanical heart program. In 2023, he and his wife launched Tche, a plant-based coffee and energy drink alternative. He lives in San Clemente with his wife and four boys and is one of my husband Neil's best friends from high school, which we'll talk about today. This episode is intensely entertaining, fun, and educational. If you've ever watched and enjoyed a medical TV drama, you will absolutely love today's interview with Fab where he tells some pretty wild stories from surgical residency. He shares his journey with us going from not even planning to get a college education to becoming a heart surgeon and why he chose that specialty. We also get to talk all about health and what you should actually be looking out for if you're over 30 and want to be heart healthy. And if Fab's drink Tche has changed your life like it has changed ours (Neil getting off energy drinks and me overcoming the energy low of postpartum depression), you'll also love hearing why and how he created Tche and the things he put into Tche as a doctor that he knew every adult needed on a daily basis. You're going to be seriously entertained and educated today and if you haven't tried Tche yet and want to, you can use our code mintarrow to get 15% off your order. Now onto the episode. Go to drinktche.com and enter code mintarrow to get 15% off your order of Tche. Time Stamps: [01:43] - Dr. Fab Sagebin and Neil are high school friends. What kind of fun did they get into? [04:30] - Fab says he barely graduated high school. What guided him to go to college and pursue science? (Hint: It was accidentally.) [07:11] - Fab recalls being a medical student at NYU in Manhattan. What was life like at that time for him? [11:41] - Fab describes the general checkpoints of becoming a medical professional based on his journey. [14:19] - What does Fab remember from some of his earlier procedures? [17:01] - Fab gives his thoughts on the importance of mentorship. What role did mentors play in his residency? [21:27] - What is an LVAD? [23:34] - Fab recalls having to evacuate the operating room during Superstorm Sandy (Hurricane Sandy) while escorting patients to safety. [26:08] - Fab talks about working in the heart health field. He says he's often mind blown. [27:58] - How should people take care of their heart health? Fab starts with these three tips.  [30:48] - Is cholesterol as important in heart health as people think? [32:32] - Corrine shares how she enjoys Tche. What flavors and drink recipes does she like? [36:06] - Changes in your diet can make significant differences in your body. [38:12] - What happens when you reset your body? [39:47] - What is Ozempic? [44:06] - Corrine shares what led her to start drinking Tche. [48:14] - Fab says he started looking for coffee alternatives, but couldn't find what fit his needs. [49:55] - A smart coffee alternative: Tche. [52:03] - How does Tche add value? [54:17] - Tche inspires new energy. [56:46] - How much caffeine is in Tche? (Hint: You have 3 Levels to choose from.) [59:01] - Neil talks about switching from energy drinks to Tche. [01:02:55] - Remember the simple things in life that fill up your energy. [01:05:25] - Experience the fullness of life. Supporting Resources: Follow along with Dr. Fabio Sagebin: YouTube channel  Instagram @fabsagebinmd Tiktok  Order Tche drinktche.com

Yes, the photograph of the episode cover is many years old. All three of us have leveled up since then.  However, this conversation is hot and fresh, like the best TOTS should be.  Here's some of the stuff we discussed: The Yellow Wallpaper Moe DeWitt is giving away shit (going for the rhyme, not accuracy - Moe DeWitt is giving away high quality merch at random times) An update on Logan, MIckey's 23 year old son, who needs a heart transplant Logan's on Twitch! Meeting another LVAD patient Logan's pulse is almost non-existent Fanny packs are back! Michigan's weather is weird Controlling the simulation Feeding tubes are the worst (according to Logan) Changing to a Tater Tot themed podcast with dipping sauces Between Two Tots How old is this podcast anyways? Ross got Burberry glasses! Bifocals vs. progressives vs. bifocal contacts Rope in a can! Wanted: One (or more) mad scientist Mickey's stylish sweater Super puffy D Does everything glow in the daylight? Drip shops Do not freeze the strudel Seeing "Starry Starry Night" Buy Sean Beagan Kiss is from Detroit?! Fuck a wet salad! Weird Bull & Bush t-Shirts Javaris, No UFOs & ghosts RRR - is that a pirate movie? Yes. "The Book of Disquiet" "The Art of War" Thanks for listening, now go review Ross on iTunes!

CardioNerds (Dr. Amit Goyal), Dr. Sonu Abraham (CardioNerds Ambassador from Lahey Hospital and Medical Center, Burlington, MA) discuss left ventricular assist devices (LVAD) and the implications of renal dysfunction with Dr. Brian Houston and Dr. Nisha Bansal. This episode will focus on the intersection of left ventricular assist devices and renal dysfunction. Patients with a combination of heart failure and renal dysfunction overall have a guarded prognosis and their management poses unique challenges to the clinician. We initially discuss the basics of an LVAD and general approach to LVAD candidacy evaluation. We then discuss specific implications of acute kidney injury, presence of preexisting CKD, and end stage renal disease in patients with/being considered for an LVAD. Risk factor identification and prognostication allows for appropriate selection of the right candidates for an LVAD in the context of renal disease. Dr. Brian Houston is the Director of the Mechanical Circulatory Support program at Medical University of South Carolina. Dr. Nisha Bansal is an Associate Professor and the Arthur Stach Family Endowed Professor in the Division of Nephrology, an investigator at the Kidney Research Institute, the Director of Nephrology Clinical and Research Education, and the Director of the Kidney-Heart Service at the University of Washington. Notes were drafted by Dr. Sonu Abraham and episode audio was edited by student Dr. Chelsea Amo-Tweneboah. Check out the CardioNerds Failure Heart Success Series Page for more heart success episodes and content! CardioNerds Heart Success Series PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls - Left Ventricular Assist Devices and Renal Dysfunction End stage renal disease (CKD on dialysis) is considered an absolute contraindication for LVAD implantation. Select young patients who are being considered for heart-kidney transplantation in the near future may be candidates for an LVAD as a bridge to heart-kidney transplantation. LVAD implantation can improve kidney function in the short term in patients with AKI primarily caused by cardio-renal syndrome. Patients with pre-existing CKD (not dialysis dependent) have a greater risk of developing AKI after LVAD implantation.   Several dialysis modalities including in-center hemodialysis, home hemodialysis, and peritoneal dialysis are available for LVAD patients. However, there are several challenges associated with each modality. An AV graft is a useful vascular access option in LVAD patients undergoing hemodialysis due to a lower risk of infection and ease of immediate use. Causes for anemia in patients with an LVAD and renal dysfunction include anemia of chronic disease, gastrointestinal bleeding, and pump thrombosis leading to hemolysis. Show notes - Left Ventricular Assist Devices and Renal Dysfunction Notes: (drafted by Dr. Sonu Abraham) What is a left ventricular assist device (LVAD) and what are its components? An LVAD supports circulation by unloading the left ventricle and providing increased cardiac output to help support organ perfusion. Use in properly selected patients is associated with improved quality of life and increased survival. The current iteration of LVADs offer continuous flow, as opposed to the older versions which employed pulsatile flow. Components of the LVAD: Inflow cannula (sucks blood from the LV) Pump Outflow cannula (dumps blood into the aorta) Percutaneous driveline Electrical controller How is a patient evaluated for LVAD candidacy? The 2 main questions to be answered during the evaluation of a patient for an LVAD are:             1. Are they sick enough? Do they have end stage heart failure?             2. Do we expect the benefits of an LVAD to outweigh the risks? ...

In this episode Alin and Colby interview Andrew (AJ) Jones. AJ developed acute heart failure and needed first an LVAD and then a heart transplant. AJ gives us the details of these procedures, how he lived his life as a fitness enthusiast afterwards, and how this shaped his future and led him to work with New England Donor Services. 

  On this episode of Woke By Accident Podcast, we are joined by Shawn Connors.  Shawn is a self proclaimed computer nerd, single father, Christian , LVAD enabled, podcaster, podcast producer, content creator, sneakerhead and foodie, owner of Connors Studios  Digital Media.  Shawn hosts the podcast 757 Renaissance Man &LVAD Talk. We discuss the impact of cardiovascular issues in the African American community. Check out Shawn's content here: https://linqapp.com/shawn_connors https://www.757renaissanceman.com/ https://www.lvadtalk.com/ Check out Woke By Accident at www.wokebyaccident.net or on your favorite streaming platforms! Sponsor Get your pack of @Poddecks now for your next podcast interview using my special link: https://www.poddecks.com?sca_ref=1435240.q14fIixEGL Music Soul Searching · Causmic Last Night's Dream — Tryezz

Up to 25% of all heart patients have advanced heart failure. Mark's guest discusses the benefits that Artificaial Inteligience is giving advance notice on heart failure. Dr. Faraz Ahmad MD is the Associate Director of Northwestern Medicine Bluhm Cardiovascular Institute.More About Dr. Faraz AhmadDr. Ahmad is a practicing heart failure cardiologist who cares for patients across the spectrum of heart failure, including patients with different types of cardiomyopathies, with advanced heart failure, and those who have undergone heart transplantation or mechanical assist device support (LVAD). He has a particular clinical interest in the diagnosis and management of patients with different types of heart failure with preserved ejection fraction, such as cardiac amyloidosis. Dr. Ahmad's research interests are in using data science, machine learning, and digital health technologies to improve quality of care for patients with heart failure and other cardiovascular diseases. His work has received support from multiple organizations, including the National Institutes of Health, the American Heart Association, the Patient-Centered Outcomes Research Institute, the Heart Failure Society of America, and the Centers for Disease Control and Prevention

In this 244th episode I welcome back Dr. Mike Essandoh and welcome for the first time Dr. Nick Kumar to discuss their recent article about using a novel hemodynamic measurement, the Pulmonary Artery Pulsatility Index (PAPI) to assess right heart function in general and in LVAD recipients specifically.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

A Left Ventricular Assist Device (LVAD) is a mechanical pump that is surgically inserted to assist the left ventricle in pumping blood to the body. In this episode you'll learn what an LVAD is, how it works and the basics for caring for patients with ventricular assist devices. A big thank-you to HCA Healthcare for sponsoring this episode. You can learn more about HCA's robust Nurse Residency Program here. Important links: Demo video of obtaining a MAP using a Doppler. Right-Sided vs Left-Sided Heart Failure: Episode 57. UCSF guide about living with a VAD. Read the episode transcript and see references here. For more articles on cardiovascular nursing, check out the collection here. Do you want to start nursing school prepared and ready to conquer? Then check out my nursing school prep course Crucial Concepts Bootcamp.     RATE, REVIEW AND FOLLOW! If this episode helped you, please take a moment to rate and review the show! This helps others find the podcast, which helps me help even more people :-) Click here, scroll to the bottom, then simply tap to rate with 5 stars and select, "write a review." I'd love to hear how the podcast has helped you! If you're not following yet, what are you waiting for? It takes just a quick moment and the episodes show up like magic every Thursday. And, when I release a bonus episode, those show up, too! You'll never miss a thing! In Apple Podcasts, just click on the three little dots in the upper right corner here. Know someone who would also love to study with me? Share the show or share specific episodes with your classmates...when we all work together, we all succeed! On Apple Podcasts, the SHARE link is in the same drop-down as the follow link. Spread the love! Thanks for studying with me! Nurse Mo